ClinicalTrials.gg
Not yet recruitingNCT07404267ORI-BCPUpdated Feb 11, 2026

Oxygen Reserve Index-Guided Oxygen Titration During Surgery in the Beach Chair Position

An interventional study of ORi-Guided FiO₂ Titration and SpO₂-Guided FiO₂ Titration in Hyperoxemia, Intraoperative Oxygen Therapy and Beach Chair Position, sponsored by Fatih Sultan Mehmet Training and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by Fatih Sultan Mehmet Training and Research Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to evaluate whether guidance by the Oxygen Reserve Index (ORi) improves inspiratory oxygen fraction (FiO₂) titration compared with conventional pulse oximetry (SpO₂)-guided oxygen administration in adult patients undergoing surgery in the beach chair position.

Oxygen therapy is routinely used during general anesthesia to prevent hypoxemia; however, excessive oxygen administration may result in hyperoxia, which has been associated with adverse cardiovascular and pulmonary effects. Standard pulse oximetry may not adequately detect hyperoxia when oxygen saturation values are high.

In this prospective comparative study, patients will receive oxygen titration guided either by SpO₂ alone or by combined ORi and SpO₂ monitoring. The primary outcome is the incidence of intraoperative hyperoxemia, assessed by arterial blood gas analysis. Secondary outcomes include intraoperative oxygenation parameters and hemodynamic variables.

Read the detailed description

This prospective study will be conducted in adult patients (ASA physical status I-III) undergoing elective orthopedic surgery in the beach chair position under general anesthesia. Following approval by the institutional ethics committee and acquisition of written informed consent, eligible patients will be included in the study.

Standard monitoring will include electrocardiography, noninvasive blood pressure, peripheral oxygen saturation (SpO₂), bispectral index (BIS), perfusion index (PI), pleth variability index (PVI), near-infrared spectroscopy (NIRS), and multiwavelength pulse co-oximetry for Oxygen Reserve Index (ORi) monitoring. Invasive arterial blood pressure monitoring will be established via radial arterial cannulation to allow continuous hemodynamic monitoring and arterial blood gas sampling.

General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by orotracheal intubation. Mechanical ventilation will be applied in volume-controlled mode with lung-protective settings. Anesthesia will be maintained using sevoflurane and remifentanil infusion, targeting bispectral index values between 40 and 60.

From anesthesia induction onward, inspiratory oxygen fraction (FiO₂) will be titrated either according to SpO₂ values alone or using combined ORi and SpO₂ guidance. In the ORi-guided group, FiO₂ adjustments will aim to maintain ORi values between 0.2 and 0.5, with reassessment at regular intervals. In the SpO₂-guided group, FiO₂ will be adjusted to maintain SpO₂ values at or above 98%, in accordance with routine clinical practice.

Hemodynamic parameters, oxygenation variables, ORi values, and cerebral oxygenation assessed by NIRS will be recorded at predefined time points during surgery and recovery. Arterial blood gas analysis will be performed to determine PaO₂ and arterial oxygen saturation.

Hyperoxemia will be defined as a PaO₂ value of 100 mmHg or greater and classified as mild or severe. The primary outcome of the study is the incidence of intraoperative severe hyperoxemia. Secondary outcomes include overall oxygenation profiles and intraoperative hemodynamic stability.

The results of this study are expected to provide evidence regarding the utility of ORi-guided oxygen titration in reducing unnecessary hyperoxia during surgery performed in the beach chair position.

02

Conditions studied

  • Hyperoxemia
  • Intraoperative Oxygen Therapy
  • Beach Chair Position
  • Cerebral Oxygenation

Browse trials for

Keywords

  • Oxygen Reserve Index
  • ORİ
  • FiO2 titration
  • Hyperoxia
  • Pulse oximetry
  • Arterial blood gas
  • Near-infrared spectroscopy
  • General anesthesia
  • Beach chair position
  • Orthopedic surgery
03

In context

Hyperoxia

115 studies on the registry are indexed under Hyperoxia; 13 are open to participants now.

This study's planned enrollment of 80 is above the median of 48 across 82 interventional studies indexed under Hyperoxia.

Browse Hyperoxia studies →

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital is the lead sponsor of 120 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18 to 65 years
  • (ASA) physical status I-III
  • Scheduled for elective orthopedic surgery in the beach chair position
  • (BMI) \<35 kg/m²
  • Ability to provide written

Exclusion criteria

Exclusion Criteria:

  • Age \<18 or ≥65 years
  • Finger deformities preventing the use of Oxygen Reserve Index (ORi) monitoring
  • Severe anemia ( \<8 g/dL)
  • Pregnancy
  • Refusal or inability to provide
  • History of stroke or significant vascular pathology
  • Severe cardiac or respiratory disease
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    ORi-Guided FiO₂ Titration

    Inspiratory oxygen fraction (FiO₂) will be titrated using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring throughout surgery.

    Other: ORi-Guided FiO₂ Titration

  • Active comparator
    SpO₂-Guided Oxygen Titration

    Inspiratory oxygen fraction (FiO₂) will be titrated based on peripheral oxygen saturation (SpO₂) values according to routine clinical practice.

    Other: SpO₂-Guided FiO₂ Titration

Interventions

  • OtherORi-Guided FiO₂ Titration

    Inspiratory oxygen fraction (FiO₂) will be adjusted throughout surgery using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring. FiO₂ will be titrated to maintain ORi values between 0.2 and 0.5, with reassessment every 2-3 minutes.

  • OtherSpO₂-Guided FiO₂ Titration

    FiO₂ will be adjusted to maintain SpO₂ at or above 98% throughout surgery.

06

What researchers measure

Primary outcomes

  1. Incidence of Intraoperative Severe Hyperoxemia

    Severe hyperoxemia will be defined as an arterial partial pressure of oxygen (PaO2) ≥200 mmHg, measured by arterial blood gas analysis at predefined intraoperative time points.

    Time frame: Perioperative/Periprocedural

Secondary outcomes

  1. Mean Peripheral Oxygen Saturation (SpO2) During Surgery

    Peripheral oxygen saturation (SpO2) measured continuously during surgery using standard pulse oximetry.

    Time frame: Perioperative/Periprocedural

  2. Mean Oxygen Reserve Index (ORi) During Surgery

    Oxygen Reserve Index (ORi) values recorded intraoperatively to evaluate oxygenation status.

    Time frame: Perioperative/Periprocedural

  3. Mean Fraction of Inspired Oxygen (FiO₂) During Surgery

    Mean fraction of inspired oxygen (FiO₂) expressed as percentage (%), averaged over the surgical period.

    Time frame: Perioperative/Periprocedural

  4. Mean Cerebral Oxygen Saturation Measured by Near-Infrared Spectroscopy During Surgery

    Cerebral regional oxygen saturation values measured intraoperatively using near-infrared spectroscopy.

    Time frame: Intraoperative period (from induction of anesthesia to end of surgery)

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Jun 2026, 4 months later.

Of 37 non-industry interventional studies with no phase under Hyperoxia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 4 months is below that.

Counting every sponsor, half of 39 studies reached it within 12 months; a quarter within 5 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2026
First posted
Feb 11, 2026
StartEst.
Feb 15, 2026
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jul 31, 2026
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07404267
Responsible party
Çağla Sancak (Resident in Anesthesiology, Fatih Sultan Mehmet Training and Research Hospital) — Principal investigator
First posted
Feb 11, 2026
Start date
Feb 15, 2026 (estimated)
Primary completion
Jun 30, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Feb 11, 2026

Study contacts

cagla sancak, md
Contact
caglasancakk@gmail.com
+905064381002 ext. +90216 578 30
cagla sancak, MD
principal investigator · ISTANBUL PROVINCIAL HEALTH DIRECTORATE FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion